Hjem › Nyrekreft › Massachusetts › Boston
Kliniske studier for Nyrekreft i Boston, MA
12 studier for Nyrekreft søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekruttererFase 1
- Research Site, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
- Dana-Farber Cancer Institute, Boston
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 3
- Research Site, Boston
- Research Site, Boston
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruttererFase 1/2
- Brigham and Women's Hospital, Boston
- Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
RekruttererFase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
Video Education With Result Dependent dIsclosure
Rekrutterer
- Dana Farber Cancer Institute, Boston
Drug Screening Using Novel IMD in Renal Cell Carcinoma
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Massachusetts General Hospital, Boston
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
RekruttererFase 2
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
Rekrutterer
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Nyrekreft-studier i andre byer
- New York City, NY15 studier
- Nashville, TN12 studier
- Houston, TX10 studier
- San Diego, CA9 studier
- St. Louis, MO9 studier
- Dallas, TX9 studier
- Washington, DC9 studier
- Seattle, WA8 studier
- Edison, NJ8 studier
- Miami, FL8 studier
- Los Angeles, CA7 studier
- Rochester, MN7 studier
Andre studier i Boston
- Brystkreft112 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)85 studier
- Metastatisk kreft63 studier
- Kolorektal kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.